Ekso Bionics Holdings, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Note 6 - Revenue (Tables)

Note 6 - Revenue (Tables)

12 Months Ended

Dec. 31, 2023

Notes Tables

Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]

		*December 31, 2023*				*December 31, 2022*
Deferred extended maintenance and support		$	3,993			$	2,124
Deferred device and advances			169				29
Total deferred revenues			4,162				2,153
Less current portion			(1,993	)			(1,121	)
Deferred revenues, non-current		$	2,169			$	1,032

		*Year Ended December 31, 2023*				*Year Ended December 31, 2022*
Beginning balance		$	2,153			$	2,695
Deferral of revenue			4,727				1,397
Recognition of deferred revenue			(2,718	)			(1,939	)
Ending balance		$	4,162			$	2,153

Disaggregation of Revenue [Table Text Block]

		*EksoHealth*				*EksoWorks*				*Total*
Device revenue		$	13,660			$	472			$	14,132
Service and support			2,821				—				2,821
Subscriptions			967				—				967
Parts and other			254				105				359
		$	17,702			$	577			$	18,279

		*EksoHealth*				*EksoWorks*				*Total*
Device revenue		$	8,305			$	588			$	8,893
Service and support			1,923				—				1,923
Subscriptions			967				136				1,103
Parts and other			528				358				886
Collaborative arrangements			107				—				107
		$	11,830			$	1,082			$	12,912